GlaxoSmithKline PLC
F:GS7
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
GlaxoSmithKline PLC
F:GS7
|
UK |
|
H
|
Hargreaves Lansdown PLC
F:DMB
|
UK |
|
F
|
Flight Centre Travel Group Ltd
F:FLI
|
AU |
|
H
|
Hoegh Autoliners ASA
OSE:HAUTO
|
NO |
|
TAL Education Group
LSE:0A2X
|
CN |
|
M
|
Moderna Inc
F:0QF
|
US |
|
Bigtincan Holdings Ltd
ASX:BTH
|
AU |
|
A
|
Active Biotech AB publ
STO:ACTI
|
SE |
|
B
|
Brookfield Business Corp
TSX:BBUC
|
US |
|
Ariston Holding NV
F:E0E
|
IT |
|
A
|
Assetwise PCL
SET:ASW
|
TH |
|
S
|
Santana Minerals Ltd
OTC:SEQP
|
AU |
|
B
|
BBMG Corp
XMUN:9BM
|
CN |
|
Mitsui Fudosan Co Ltd
OTC:MTSFF
|
JP |
|
F
|
Fresenius SE & Co KGaA
XHAM:FRE
|
DE |
|
C
|
China International Capital Corp Ltd
F:CIM
|
CN |
|
C
|
CSP International Fashion Group SpA
MIL:CSP
|
IT |
|
Humana Inc
NYSE:HUM
|
US |
|
Nextedia SA
F:9KA
|
FR |
|
Storagevault Canada Inc
F:0SV
|
CA |
|
F
|
Forgent Power Solutions, Inc
NYSE:FPS
|
US |
|
Beiersdorf AG
OTC:BDRFF
|
DE |
Wall St Price Targets
GS7 Price Targets Summary
GlaxoSmithKline PLC
According to Wall Street analysts, the average 1-year price target for GS7 is 17.29 EUR with a low forecast of 11.88 EUR and a high forecast of 23.34 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GS7's stock price target?
Price Target
17.29
EUR
According to Wall Street analysts, the average 1-year price target for GS7 is 17.29 EUR with a low forecast of 11.88 EUR and a high forecast of 23.34 EUR.
What is the Revenue forecast for GlaxoSmithKline PLC?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 8 years is 3%.
What is the Gross Profit forecast for GlaxoSmithKline PLC?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 8 years is 3%.
What is the Operating Income forecast for GlaxoSmithKline PLC?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 8 years is 4%.
What is the Pre-Tax Income forecast for GlaxoSmithKline PLC?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 1%. The projected CAGR for the next 3 years is 14%.
What is the Net Income forecast for GlaxoSmithKline PLC?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Net Income has been 2%. The projected CAGR for the next 8 years is 6%.
